Fig. 2

Intrahepatic recurrence-free survival (a), distant metastasis-free survival (b), and local control rates (c) of all patients according to alpha-fetoprotein normalization
Intrahepatic recurrence-free survival (a), distant metastasis-free survival (b), and local control rates (c) of all patients according to alpha-fetoprotein normalization